Anne Borgman
CURISAbout Anne E. Borgman, M.D.
Independent director at Curis since October 2022; age 57. Hematology/oncology physician with senior R&D leadership roles across biotech and pharma. Education includes B.S. in biochemistry (University of Illinois, Urbana‑Champaign), M.D. (Loyola University Chicago), pediatrics residency (Baylor College of Medicine), pediatric heme/onc and BMT fellowship (UCLA), and Stanford Executive Program (GSB). Currently serves as a public-company director at NextCure, Inc., and director at private NiKang Therapeutics; founded AEB Hematology Oncology Development Consulting in Nov 2021 . Curis’ board determined in March 2025 that Dr. Borgman is independent